the thrombolysis in myocardial infarction ( timi ) trial phase i was designed to compare the efficacy and side effects of intravenous recombinant tissue-type plasminogen activator ( rt-pa ) and intravenous streptokinase ( sk ) in patients with acute myocardial infarction ( ami ) .
C0027051
timi
C0038418
streptokinase